# Ipamorelin: What it changes and what it didn’t > Ipamorelin: What the human trial found | pureformpeptide — Ipamorelin was designed to raise growth hormone while limiting other hormone rises. Its one Phase 2 human trial missed the main goal. **01 / IPAMORELIN HUMAN TRIAL** Researchers made this peptide from five protein pieces to raise growth hormone. You’ll see why the failed test leaves you without a proved benefit for your body. ## What ipamorelin raised and what people gained Researchers made ipamorelin from five protein building blocks. They wanted growth hormone to rise while other hormones stayed steady. Earlier peptides also raised a stress hormone and a milk-making hormone. Ipamorelin was meant to leave those hormones alone. It attaches where ghrelin, your hunger hormone, normally acts. That can prompt your growth gland. The idea worked in early tests. The human result was much less useful. One Phase 2 trial, a middle-stage test, followed 114 adults. All were healing after bowel surgery [3]. The main goal wasn’t met. People didn’t return to meals clearly sooner. A small study tracked how your body clears ipamorelin [4]. It didn’t test whether anyone felt better. No Phase 3 trial, the larger confirming test, followed. No country has approved ipamorelin as a drug. In 2024, federal advisers said local pharmacies shouldn’t make custom batches. Sport rules also ban ipamorelin. You won’t find an amount for human use here. You’ll see the finding from each study. You don’t have a proved benefit for your body. You’ll get the strongest human answer from the failed trial. ## How ipamorelin was made to last longer Scientists began with an older lab-made peptide marked 1 in its lab name. They kept two nearby protein pieces from its middle. They then changed the first piece, called position 1. Other changes also slowed the body’s breakdown of it. The full chemical name won’t answer your question. What happened to people matters more. Ipamorelin was made to last longer in the body. It was also made to attach at one place on a cell. Your hunger hormone acts at that same place. That may explain reports of feeling hungrier. Ipamorelin isn’t a blend with CJC-1295. It’s a separate research compound. No major drug agency has approved it. Approval hasn’t come from any country. Research-labelled ipamorelin remains on sale; prescription requests call for an individual clinical decision. [FDA’s safety list](https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks) keeps ipamorelin acetate in Category 2 for 503B outsourcing facilities. You don’t have an approved medicine here. How scientists built it can’t show whether it helps you. Only a good human test can do that. ## What ipamorelin changes after it reaches the growth gland Ipamorelin attaches to a protein on your growth gland. Growth hormone then leaves your gland. Rats and pigs received more than was needed for that rise. Two other hormones still stayed steady [1][5]. Another hormone tied to stress also stayed near its old level. That set ipamorelin apart in early work. Two older compounds, marked 6 and 2 in lab notes, raised more unwanted hormones. Ipamorelin caused fewer of those rises. CJC-1295 works through your growth gland another way. That’s why lab workers have paired the two. The pair hasn’t shown a human health gain. A good trial of both is still missing. The protein that ipamorelin attaches to also sits on your gut nerves. Some of those nerves move food forward. That fact led to the bowel-surgery trial. The hoped-for help didn’t appear. Cells in your pancreas may respond too. They can then change insulin release. Parts of your brain tied to hunger may respond as well. That fits reports of more hunger. You don’t need every lab name. You’ll learn more from the failed human trial. ## What happened in the surgery trial and animal tests The Phase 2 surgery result gives the strongest human answer. It didn’t show a clear benefit. The trial included 114 adults after part of the bowel was removed. Treatment could last up to 7 days. People taking ipamorelin ate sooner on paper. The small difference could have happened by chance. Both groups reported many new health problems. **The main goal wasn’t met** [3]. A second human study used healthy men. Each study level included 8 men. They received five brief vein drips. Each group received a different amount. Higher amounts put more ipamorelin in the blood. About 2 hours passed before the body cleared half. Growth hormone was highest near 40 minutes [4]. Only two reports in people exist. Rats received 18, 90, or 450 micrograms a day. They got three daily shots across 15 days. Adult female rats grew bone faster. Their overall growth factor 1, a liver-made growth signal, didn’t change [5]. A 2024 ferret study found 24% less weight loss. The animals had received cisplatin, a cancer drug that can cause sickness and weight loss. Ipamorelin didn’t stop vomiting. Another compound cut early vomiting by 60% [1]. A different compound harmed rat heart muscle. Higher amounts caused more damage [2]. Ipamorelin wasn’t that tested compound. The result only shows a harm that needs watching. You can’t use those study amounts as your plan. You’ll need to put the failed surgery trial first. ## What people report and which harms remain unknown People using research material tell many stories. **They’re personal reports; no controlled trial tested them**. No one checked the purity of all that material. The amount and way people used it also varied. Deeper sleep is the most common good report. Some people notice it by week one or two. Vivid dreams also come up early. People mention faster recovery and less soreness. Some say their build looked leaner after several weeks or months. Food and exercise could cause the same change. One person’s story can’t sort out those causes. It also can’t tell you how your body would respond. Flushing or a head rush gets reported often. It may begin soon after a shot. The flush may last for an hour. Some compare the feeling with a niacin flush. People also report tingling hands or feet. Mild water gain and puffiness can follow. A shot may be followed by more hunger. People also report feeling lightheaded or foggy. Redness or itching can mark the shot site. Some say the effect fades over months. The growth-gland protein can raise growth factor 1, a growth signal made by your liver. Growth factor 1 helps all cells grow, including harmful ones. A cancer caused by ipamorelin hasn’t appeared in a study. The concern comes from how cells grow. Ipamorelin may change insulin release from your pancreas. Growth hormone can also weaken insulin’s effect. If your blood sugar starts high, the result is unknown. No sound long-term test answers your question. Water gain can strain your heart. Long work on the same cell protein also raised a warning in rats [2]. Human safety work had only a 7-day span or one visit. Shots under the skin haven’t been tracked well [3][4]. You can’t take someone else’s report as proof. You’ll need your answer from a controlled trial. ## How ipamorelin differs from the other three compounds Ipamorelin raised fewer unwanted hormones in early work. That didn’t become a clear human benefit. Its one Phase 2 trial missed the main goal [3]. That result matters more than the lab idea. [CJC-1295](/cjc-1295) raises growth hormone for days. Ipamorelin causes a shorter rise. Researchers thought the two might work better together. No sound human trial has proved that. [NAD+](/nad) and [MOTS-c](/mots-c) work inside cells instead. They don’t act first on the growth gland. Set all four beside each other on the [comparison page](/compare). Put the human result first. A neat lab idea can’t settle your choice. Look for what people actually gained. ![Ipamorelin acting on the growth gland](/images/ipamorelin.webp) --- An independent literature desk for the growth-hormone axis and longevity research — what the peer-reviewed record actually shows, stated plainly and cited precisely.